Skip to main content
. 2019 Jun 13;11(7):e10292. doi: 10.15252/emmm.201910292

Table 2.

Concentrations for synergic combinations in h676 GSCs

Combination Concentration PI3Ki (nM) Concentration Compound 2 (nM)
PI3Ki + HSP90i (Geldanamycin) 0.2–0.4 0.005
PI3Ki + docetaxel 0.2–0.4 0.001
PI3Ki + gemcitabine 0.2–0.4 0.006
PI3Ki + ERKi 0.2–0.4 0.3
PI3Ki + MEKi 0.2–0.4 0.24
PI3Ki + RTKi (Dasatinib) 0.2–0.4 10